Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
iShares S&P 500 Growth ETF
IVW
$76.1B
| $668K | ﹤0.01% |
18,620
-109,340
| -85% | -$3.85M |
|
|
BBBY
2702
DELISTED
Bed Bath & Beyond Inc
BBBY
| $668K | ﹤0.01% |
28,456
+13,035
| +85% | +$365K |
|
2703
Arrow Financial
AROW
$707M
| $667K | ﹤0.01% |
23,197
+3,684
| +19% | +$97.2K |
|
2704
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $667K | ﹤0.01% |
29,435
+4,482
| +18% | +$103K |
|
2705
Ennis
EBF
$543M
| $667K | ﹤0.01% |
33,966
-46,719
| -58% | -$893K |
|
2706
United Fire Group
UFCS
$1.38B
| $667K | ﹤0.01% |
14,550
-55,487
| -79% | -$2.4M |
|
|
IDTI
2707
CALL
DELISTED
Integrated Device Technology I
IDTI
| $665K | ﹤0.01% |
+25,000
| New | +$635K |
|
|
SEI
2708
Solaris Energy Infrastructure
SEI
$3.48B
| $664K | ﹤0.01% |
+38,074
| New | +$524K |
|
2709
Luxfer Holdings
LXFR
$459M
| $663K | ﹤0.01% |
53,215
+41,090
| +339% | +$512K |
|
|
NCOM
2710
DELISTED
National Commerce Corporation
NCOM
| $663K | ﹤0.01% |
+15,488
| New | +$620K |
|
|
VISN
2711
Vistance Networks Inc
VISN
$2.55B
| $660K | ﹤0.01% |
19,865
-1,671,522
| -99% | -$57.1M |
|
|
BGC
2712
PUT
DELISTED
General Cable Corporation
BGC
| $660K | ﹤0.01% |
+35,000
| New | +$627K |
|
2713
West Pharmaceutical
WST
$24.5B
| $659K | ﹤0.01% |
6,846
-723,479
| -99% | -$65.5M |
|
2714
AppFolio
APPF
$7.9B
| $657K | ﹤0.01% |
13,711
+619
| +5% | +$24.3K |
|
|
IBTX
2715
DELISTED
Independent Bank Group, Inc.
IBTX
| $654K | ﹤0.01% |
10,854
-102,383
| -90% | -$5.96M |
|
2716
BlackRock Corporate High Yield Fund
HYT
$1.35B
| $653K | ﹤0.01% |
57,827
+21,545
| +59% | +$240K |
|
2717
Calamos Strategic Total Return Fund
CSQ
$3.34B
| $652K | ﹤0.01% |
53,736
+32,942
| +158% | +$391K |
|
|
CCRN
2718
DELISTED
Cross Country Healthcare
CCRN
| $651K | ﹤0.01% |
45,740
-179,924
| -80% | -$2.25M |
|
|
PINC
2719
PUT
DELISTED
Premier
PINC
| $651K | ﹤0.01% |
+20,000
| New | +$679K |
|
|
AXE
2720
DELISTED
Anixter International Inc
AXE
| $651K | ﹤0.01% |
7,655
-4,321
| -36% | -$332K |
|
|
JUNO
2721
DELISTED
Juno Therapeutics, Inc.
JUNO
| $651K | ﹤0.01% |
14,510
-414,458
| -97% | -$14.1M |
|
|
UFAB
2722
DELISTED
Unique Fabricating, Inc.
UFAB
| $648K | ﹤0.01% |
76,630
-1,271
| -2% | -$10.3K |
|
2723
Vericel Corp
VCEL
$2.21B
| $644K | ﹤0.01% |
+107,302
| New | +$412K |
|
2724
Fortress Biotech
FBIO
$94.4M
| $643K | ﹤0.01% |
9,693
+8,966
| +1,233% | +$604K |
|
2725
First Financial Bankshares
FFIN
$4.83B
| $640K | ﹤0.01% |
+28,336
| New | +$593K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.